Group One Trading’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$413K Sell
1,417
-249
-15% -$82.4K ﹤0.01% 3582
2026
Q2
$558K Buy
1,666
+1,537
+1,191% +$487K ﹤0.01% 3394
2026
Q1
$41.6K Sell
129
-5,410
-98% -$1.67M ﹤0.01% 5395
2025
Q4
$1.63M Sell
5,539
-11,089
-67% -$2.07M ﹤0.01% 2454
2025
Q3
$881K Buy
+16,628
New +$806K ﹤0.01% 3164
2025
Q2
– Sell
-10,927
Closed -$416K – 8505
2025
Q1
$414K Buy
+10,927
New +$682K ﹤0.01% 3285
2024
Q4
– Sell
-60,818
Closed -$4.4M – 7815
2024
Q3
$3.5M Buy
+60,818
New +$3.29M 0.01% 1283
2024
Q2
– Sell
-13,522
Closed -$639K – 7326
2024
Q1
$825K Buy
13,522
+13,362
+8,351% +$599K ﹤0.01% 2257
2023
Q4
$3.56K Sell
160
-17
-10% -$306 ﹤0.01% 6640
2023
Q3
$4.53K Buy
177
+165
+1,375% +$3.12K ﹤0.01% 6742
2023
Q2
$206 Sell
12
-2,501
-100% -$38.3K ﹤0.01% 7467
2023
Q1
$30.5K Buy
+2,513
New +$106K ﹤0.01% 5227
2022
Q4
– Sell
-248
Closed -$8K – 7909
2022
Q3
$8K Sell
248
-26
-9% -$1.3K ﹤0.01% 6640
2022
Q2
$10K Buy
274
+253
+1,205% +$27K ﹤0.01% 6768
2022
Q1
$3K Buy
+21
New +$4.31K ﹤0.01% 7643

Other funds holding PRAX

Group One Trading's PRAX Position: Q3 2026 in Review

Group One Trading reduced its Praxis Precision Medicines (PRAX) stake by 15% in Q3 2026, selling an estimated $82.4K and leaving 1,417 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #3582.

Group One Trading first reported a position in PRAX in Q1 2022 and has held it in 15 quarters since. The position peaked at $3.5M in Q3 2024. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Group One Trading held 1,417 shares of Praxis Precision Medicines worth $413K as of Q3 2026.
  • Group One Trading sold 249 Praxis Precision Medicines shares in Q3 2026, an estimated $82.4K.
  • Praxis Precision Medicines made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #3582 holding.
  • Group One Trading first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 15 quarters since.
  • Group One Trading's Praxis Precision Medicines position peaked at $3.5M in Q3 2024.
  • 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.